TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), an artificial intelligence-driven digital health company focusing on improving brain health, today announces that it will incorporate OpenAI’s technology, ChatGPT, in its BRAIN AGE™ Artificial Intelligence (“AI”) Product Suite, which already includes a variety of API interfaces to build AI and machine learning functions, to further enhance the Company’s novel Brain Health Digital Platform to assess overall brain health and presence of cognitive impairment in athletes, and those diagnosed with a mental health and neurodegenerative condition.
DiagnaMed’s Brain Health Digital Platform comprises several assessment tools generated rapidly by self-report or clinician-observed measures, each capturing different aspects of brain health to evaluate overall brain health, output a patient risk score, and provide actionable points to develop precision medicine-like, personalized treatment plans and interventions. As part of the BRAIN AGE™ AI Product Suite, the Brain Health Platform will also include unique brain training, games, education, and coaching applications. The Company expects to launch the Brain Health Digital Platform as a general clinical tool in May 2023.
“Our Brain Health Digital Platform, which is part of our BRAIN AGE™ AI product suite, offers licensed professionals a novel brain health assessment tool, patient risk score, and helpful intervention plans and techniques, incorporating OpentAI’s technology, ChatGPT, with the aim to improve brain health and brain age of patients,” said Fabio Chianelli, Chairman of DiagnaMed. “We expect to launch the Brain Health Digital Platform in the U.S. and Canada in Q2-2023 for use in sports, mental health and neurology clinics that are committed to improving the brain health of over 50 million people with mental health and neurological disorders.”